Funke, Manuela; Geiser, Thomas (2016). [Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis]. Therapeutische Umschau, 73(1), pp. 25-29. Huber 10.1024/0040-5930/a000751
Full text not available from this repository.Recent studies have shown efficacy to slow the decrease of forced vital capacity in patients with idiopathic pulmonary fibrosis. This summary refers to recent anti-fibrotic medications and describes current studies, indication for treatment and side effects, as well as discusses open questions of treatment.
Item Type: |
Journal Article (Further Contribution) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology |
UniBE Contributor: |
Funke, Manuela, Geiser, Thomas (A) |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0040-5930 |
Publisher: |
Huber |
Language: |
German |
Submitter: |
Rahel Holderegger |
Date Deposited: |
22 Mar 2017 15:28 |
Last Modified: |
29 Mar 2023 23:35 |
Publisher DOI: |
10.1024/0040-5930/a000751 |
PubMed ID: |
26884217 |
URI: |
https://boris.unibe.ch/id/eprint/93081 |